KANSAS CITY, Kan., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in the $5.5 Billion U.S. Anxiety Market, and the $11.6 Billion Anxiety Market ...
There is no best medication for generalized anxiety disorder (GAD). Doctors base treatment plans on factors such as the severity of symptoms and the person’s response to the recommended drugs. However ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results